within Pharmacolibrary.Drugs.ATC.N;

model N05AA01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.2,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.022,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00525,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.024,
    k12             = 0.78,
    k21             = 0.78
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N05AA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Chlorpromazine is a typical antipsychotic drug of the phenothiazine class, historically used for the treatment of schizophrenia, psychotic disorders, severe nausea and vomiting, and intractable hiccups. Though still in clinical use in some countries, it has largely been replaced by atypical antipsychotics due to its side effect profile.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Nordt, SP, &amp; Clark, RF (1997). Midazolam: a review of therapeutic uses and toxicity. <i>The Journal of emergency medicine</i> 15(3) 357–365. DOI:<a href=\"https://doi.org/10.1016/s0736-4679(97)00022-x\">10.1016/s0736-4679(97)00022-x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9258787/\">https://pubmed.ncbi.nlm.nih.gov/9258787</a></p></li><li><p>Whitfield, LR, et al., &amp; Clark, ML (1978). Chlorpromazine metabolism. IX. Pharmacokinetics of chlorpromazine following oral administration in man. <i>Journal of pharmacokinetics and biopharmaceutics</i> 6(3) 187–196. DOI:<a href=\"https://doi.org/10.1007/BF01312261\">10.1007/BF01312261</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/671225/\">https://pubmed.ncbi.nlm.nih.gov/671225</a></p></li><li><p>Dahl, SG, &amp; Strandjord, RE (1977). Pharmacokinetics of chlorpromazine after single and chronic dosage. <i>Clinical pharmacology and therapeutics</i> 21(4) 437–448. DOI:<a href=\"https://doi.org/10.1002/cpt1977214437\">10.1002/cpt1977214437</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/849674/\">https://pubmed.ncbi.nlm.nih.gov/849674</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N05AA01;
